RTTNews BiotechDoubao · 实盘不做把握 7/10不做原因:已被定价
北京时间·🕒 发布 22:08:46·⟳ 抓取 22:45:16 +36m30s·⚡ 决策 09-14 22:48:15 +2m59s·43.2 天前
Biofrontera的Ameluz获FDA批准用于浅表性基底细胞癌，获批早于9月28日PDUFA但股价先跌后回收、利好已被充分预期
基本面是真实利好且提前获批，但催化在数周前已明牌（9月28日PDUFA自Q2财报公开），股价提前上涨23%、逼近52周高点，消息当日盘中一度跌6.5%呈典型见光死；新增收入要到2027年才体现，标的为亏损微盘股、流动性差，追多风险收益比不佳；获批本身是正面事件，不构成做空红线要求的强空催化，故双向不做。
📄 原文RTTNews Biotech↗ 原文
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 Biofrontera Inc.（BFRI.US）
利好已高度price-in：PDUFA日(9月28日)自8月Q2财报公开、股价20日+23%逼近52周高点，获批当日盘中先跌6.5%呈见光死；新增收入2027年才兑现，标的为市值约2270万美元、日均成交约110万美元的亏损微盘股，追多风险收益比差。反向亦不做：FDA批准是净正面事件，以sell-the-news为由开空属于弱催化，不满足做空红线。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Ameluz sBCC获批是真实、提前落地的利好，但PDUFA时点早已公开、股价20日涨23%且在52周高位，市场以先跌6%兑现预期，商业化收入要等到2027Q1；微盘亏损股流动性差，多空均无edge，回避。
消息传播链
- 公司在Q2财报中披露sBCC的PDUFA目标日为2026-09-28，获批预期自此进入市场定价
- 媒体报道FDA设定9月28日PDUFA日，BFRI当日上涨6.2%，事件前继续抢跑
- 公司正式宣布FDA批准Ameluz红光PDT用于sBCC，较PDUFA日提前约两周市场反应:盘前区间1.51-1.62美元，开盘后一度下挫
- 报道时股价1.4449美元、跌6.48%，标题直接点明"获批仍下跌"，典型sell-the-news市场反应:BFRI -6.5%
- 2026-09-14 10:45 ET市场反应Futu行情非一手股价回升至1.5303美元、仅跌1.27%，量比约2倍，市场对利好分歧但未形成单边上行市场反应:BFRI -1.27%，成交约181万美元
关键理由
- 不做多：9月28日PDUFA自8月Q2财报即为明牌，股价13周指数100→161、20日+23%，当日盘中-6.5%显示获利了结，提前两周获批的surprise不足以驱动新一轮重定价
- 不做空：FDA批准本身是净利好且数据扎实(76% vs 19%)，不能以sell-the-news或估值高为由开空，收入端2027年启动也不构成立刻的盈利损害
主要风险
- 若后续FDA标签无限制且公司给出超预期的sBCC销售峰值指引，提前获批可能在未来数日被重新定价向上，回避将踏空
- 微盘股(市值约2270万美元、日均成交额约110万美元)波动极大，任何方向都面临点差和冲击成本风险
反向证据
- 做多前查反向 · 来源 web · 日期 2026-09-14 · 影响 weakens
公司为亏损企业(PE TTM为负、市值仅约2270万美元)，sBCC外用市场已有手术、imiquimod、5-FU等成熟竞争疗法，且微盘biotech历史上有融资稀释传统；叠加利好当日盘中-6.5%，反向证据削弱做多
检索:Biofrontera BFRI 近期 利空 现金 稀释 增发 竞争 sBCC 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-09-14 · 影响 invalidates
未发现标签限制、批准瑕疵或公司层面新增利空；数据扎实(组织学清除76% vs 19%)、提前获批、Q2收入增长33%，正面基本面不支持做空
检索:Biofrontera Ameluz sBCC approval label restriction commercial uptake 原文 ↗
先例如何影响了这次决策
对本次决策的影响:强化不追多的结论；做空不被允许(正面事件、弱理由)，故先例不改变双向AVOID
方向:未构建量化先例面板；当日盘中价格反应本身(获批即跌6%后小幅回收)已直接显示本事件的sell-the-news特征
涨幅量级:不足以校准正向涨幅：明牌PDUFA提前获批的微盘biotech缺乏干净对齐样本，且结论不依赖涨幅校准
形态:本事件自身的盘中轨迹(利好发布→-6.5%→回收至-1.3%)与8月下旬以来多轮PDUFA消息后冲高回落的节奏一致，支持见光死判断
工具执行结果 · 成功 3 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 23 ms
{"result": "search_processed_events:agent query=`bfri ameluz bf-rhodoled pdt basal cell carcinoma fda | biofrontera ameluz fda approval superficial basal cell carcinoma snda | biofrontera sbcc pdufa september 2026 decision`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query - stock_quote 成功 stock_tools HTTP · 861 ms
{ - web_search 成功 doubao_search · 2,117 ms
豆包搜索结果（原始查询:Biofrontera Ameluz FDA approval superficial basal cell carcinoma September 2026 expected PDUFA；API SearchType:web）
原文全文
展开原文 · 8,445 字
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Intraday Alerts
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
By
RTTNews Staff Writer
✉
Published:
9/14/2026 10:08 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Monday, Biofrontera Inc. (
BFRI
) announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application for Ameluz topical gel, 10%, in combination with photodynamic therapy using the BF-RhodoLED lamp series, for the treatment of superficial Basal Cell Carcinoma in adults.
The approval is backed by the findings of the company's Phase 3 trial with a primary endpoint of a composite of both clinical and histological complete response of a main target lesion 12 weeks after the start of the last photodynamic therapy cycle.
The study found that 76 percent of participants treated with Ameluz saw histological clearance of the main target lesion compared to 19 percent in the placebo group, and 83 percent from Ameluz arm achieved complete clinical clearance of all target lesions compared with 21 percent from placebo group.
With this approval, Ameluz becomes the first and only photodynamic therapy drug approved by the FDA for the treatment of a skin cancer, and the only topical PDT in the United States indicated to treat both a pre-cancerous skin condition, actinic keratosis, and a skin cancer.
Moving ahead, the company plans to officially launch superficial Basal Cell Carcinoma indication late in the fourth quarter of 2026 through the first quarter of 2027 with its existing commercial organization and installed lamp base.
BFRI was trading currently at $1.4449, down 6.48 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
Looking to Invest in the Best Biotech Stocks? Subscribe to
RTT Biotech Investor
.
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Next Story
Latest Updates on Middle East War
Futures Pointing To Initial Pullback On Wall Street
September 14, 2026 08:55 ET
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
Biofrontera (BFRI) Advances Ameluz PDT For Multiple Skin Conditions, Eyes September FDA Decision
Biofrontera Posts Strong Q2 2026 Results On 33% Revenue Growth
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Google Wallet Rolls Out Full-Screen Redesign For Passes On Android
September 11, 2026 17:41 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Intraday Alerts
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
By
RTTNews Staff Writer
✉
Published:
9/14/2026 10:08 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Monday, Biofrontera Inc. (
BFRI
) announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application for Ameluz topical gel, 10%, in combination with photodynamic therapy using the BF-RhodoLED lamp series, for the treatment of superficial Basal Cell Carcinoma in adults.
The approval is backed by the findings of the company's Phase 3 trial with a primary endpoint of a composite of both clinical and histological complete response of a main target lesion 12 weeks after the start of the last photodynamic therapy cycle.
The study found that 76 percent of participants treated with Ameluz saw histological clearance of the main target lesion compared to 19 percent in the placebo group, and 83 percent from Ameluz arm achieved complete clinical clearance of all target lesions compared with 21 percent from placebo group.
With this approval, Ameluz becomes the first and only photodynamic therapy drug approved by the FDA for the treatment of a skin cancer, and the only topical PDT in the United States indicated to treat both a pre-cancerous skin condition, actinic keratosis, and a skin cancer.
Moving ahead, the company plans to officially launch superficial Basal Cell Carcinoma indication late in the fourth quarter of 2026 through the first quarter of 2027 with its existing commercial organization and installed lamp base.
BFRI was trading currently at $1.4449, down 6.48 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
Looking to Invest in the Best Biotech Stocks? Subscribe to
RTT Biotech Investor
.
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Next Story
Latest Updates on Middle East War
Futures Pointing To Initial Pullback On Wall Street
September 14, 2026 08:55 ET
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA
Biofrontera (BFRI) Advances Ameluz PDT For Multiple Skin Conditions, Eyes September FDA Decision
Biofrontera Posts Strong Q2 2026 Results On 33% Revenue Growth
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Google Wallet Rolls Out Full-Screen Redesign For Passes On Android
September 11, 2026 17:41 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。